Eaton Vance Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$593K Sell
8,004
-3
-0% -$222 ﹤0.01% 1315
2022
Q2
$522K Sell
8,007
-1,344
-14% -$87.6K ﹤0.01% 1364
2022
Q1
$591K Sell
9,351
-405
-4% -$25.6K ﹤0.01% 1485
2021
Q4
$517K Buy
9,756
+433
+5% +$22.9K ﹤0.01% 1326
2021
Q3
$609K Sell
9,323
-389,861
-98% -$25.5M ﹤0.01% 1179
2021
Q2
$26.6M Sell
399,184
-636,369
-61% -$42.4M 0.04% 396
2021
Q1
$115M Buy
1,035,553
+78,498
+8% +$8.71M 0.17% 132
2020
Q4
$114M Sell
957,055
-115,614
-11% -$13.7M 0.18% 124
2020
Q3
$93.6M Buy
1,072,669
+136,643
+15% +$11.9M 0.17% 127
2020
Q2
$83.8M Buy
936,026
+356,015
+61% +$31.9M 0.17% 128
2020
Q1
$57.8M Buy
580,011
+317,460
+121% +$31.6M 0.14% 138
2019
Q4
$30.2M Buy
262,551
+45,945
+21% +$5.28M 0.06% 265
2019
Q3
$27.3M Buy
216,606
+12,731
+6% +$1.61M 0.06% 260
2019
Q2
$24.5M Buy
203,875
+53,819
+36% +$6.48M 0.05% 274
2019
Q1
$13.1M Buy
150,056
+145,582
+3,254% +$12.7M 0.03% 358
2018
Q4
$448K Hold
4,474
﹤0.01% 1013
2018
Q3
$513K Sell
4,474
-149
-3% -$17.1K ﹤0.01% 1019
2018
Q2
$415K Sell
4,623
-4,593
-50% -$412K ﹤0.01% 1040
2018
Q1
$674K Buy
9,216
+4,623
+101% +$338K ﹤0.01% 1047
2017
Q4
$267K Buy
4,593
+29
+0.6% +$1.69K ﹤0.01% 1070
2017
Q3
$205K Buy
+4,564
New +$205K ﹤0.01% 1075
2017
Q1
Sell
-11,281
Closed -$453K 1041
2016
Q4
$453K Sell
11,281
-8,165
-42% -$328K ﹤0.01% 875
2016
Q3
$704K Buy
+19,446
New +$704K ﹤0.01% 785
2015
Q2
Sell
-4,526
Closed -$203K 941
2015
Q1
$203K Buy
+4,526
New +$203K ﹤0.01% 915